Skip to main content

Advertisement

Log in

Down syndrome live births following assisted reproductive technology in Japan: a nationwide survey between 2007 and 2016

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

The use of assisted reproductive technology (ART) and prenatal genetic testing have become more widespread in line with an increase in maternal age. However, the effect of the introduction of non-invasive prenatal testing (NIPT) in April 2013 on pregnancy outcomes in Japan, including the prevalence of Down syndrome live births following ART, has not been investigated. This study aimed to evaluate the trends in the prevalence of Down syndrome live births following ART in Japan.

Methods

This population-based retrospective study used the Japanese nationwide ART registry. All clinical pregnancies resulting in live births, stillbirths, and termination of pregnancy (TOP) following ART from 2007 to 2016 were included. Pregnancy outcomes involving infants with Down syndrome were evaluated.

Results

Among 351,808 pregnancies, the proportion of mothers with advanced age increased significantly from 2007 to 2016 (from 49.5 to 62.4% and 8.9 to 17.8% for mothers aged ≥ 35 and ≥ 40 years, respectively). The proportion of live births with Down syndrome was 77.3% in 2007, which remained consistent until 2012, but then decreased significantly to 45.1% after 2013 (P < 0.001). The prevalence of Down syndrome live births increased up to 2012 (19.5/10,000 live births), decreased significantly in 2013 (12.1/10,000 live births), and then remained almost stable (11.1–14.7/10,000 live births).

Conclusion

The introduction of NIPT balanced the prevalence of Down syndrome live births following ART with recent increasing maternal age in Japan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. OECD. OECD family database 2019, available at (http://www.oecd.org/els/family/database.htm). Accessed 08 Feb 2021

  2. Cabinet Office. Declining Birthrate White Paper (In Japanese), available at (https://www8.cao.go.jp/shoushi/shoushika/whitepaper/measures/w-2020/r02pdfhonpen/r02honpen.html). Accessed 20 May 2022

  3. Ishihara O, Jwa SC, Kuwahara A, Katagiri Y, Kuwabara Y, Hamatani T, et al. Assisted reproductive technology in Japan: a summary report for 2018 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2021;20:3–12.

    Article  CAS  Google Scholar 

  4. Adamson GD, de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, et al. International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2016. [Internet]. accessed on 13/Sep/2020. Available from: https://secureservercdn.net/198.71.233.47/3nz.654.myftpupload.com/wp-content/uploads/ICMART-ESHRE-WR2016-FINAL-20200901.pdf

  5. Breart G. Delayed childbearing. Eur J Obstet Gynecol Reprod Biol. 1997;75:71–3.

    Article  CAS  Google Scholar 

  6. Shibata M, Akaishi R, Sasaki A, Ogawa K, Nishiyama M, Wada S, et al. Pregnant women’s preferences for prenatal genetic testing: a single-center study in Japan. J Obstet Gynaecol Res. 2020;46:1972–6.

    Article  Google Scholar 

  7. Hunt L, Peterson M, Sinnott S, Sutton B, Cincotta R, Duncombe G, et al. Uptake of invasive prenatal tests in pregnancies conceived via assisted reproductive technologies: the experience in Queensland, Australia. Prenat Diagn. 2012;32:1049–52.

    Article  Google Scholar 

  8. Sasaki A, Sawai H, Masuzaki H, Hirahara F, Sago H. Low prevalence of genetic prenatal diagnosis in Japan. Prenat Diagn. 2011;31:1007–9.

    Article  Google Scholar 

  9. Sasaki A, Sago H, Yoshihashi H, Yamada S, Miyake H, Suzumori N, et al. Current status of prenatal diagnosis in Japan 1998–2016. Nihon Shusanki-Shinseiji Gakkai Zasshi (in Japanese). 2018;54:101–7.

    Google Scholar 

  10. Crombag NM, Vellinga YE, Kluijfhout SA, Bryant LD, Ward PA, Iedema-Kuiper R, et al. Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res. 2014;14:437.

    Article  Google Scholar 

  11. Vassy C, Rosman S, Rousseau B. From policy making to service use. Down’s syndrome antenatal screening in England, France and the Netherlands. Soc Sci Med. 2014;106:67–74.

    Article  Google Scholar 

  12. Lou S, Petersen OB, Jorgensen FS, Lund ICB, Kjaergaard S, Danish Cytogenetic Central Registry Study G, et al. National screening guidelines and developments in prenatal diagnoses and live births of Down syndrome in 1973–2016 in Denmark. Acta Obstet Gynecol Scand. 2018;97:195–203.

    Article  Google Scholar 

  13. Sago H, Sekizawa A, Japan Nc. Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience. Prenat Diagn. 2015;35:331–6.

    Article  Google Scholar 

  14. Ishihara O, Jwa SC, Kuwahara A, Ishikawa T, Kugu K, Sawa R, et al. Assisted reproductive technology in Japan: a summary report for 2016 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2019;18:7–16.

    Article  Google Scholar 

  15. de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, Banker M, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology 2012dagger. Hum Reprod. 2020;35:1900–13.

    Article  Google Scholar 

  16. Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther. 1995;10:356–67.

    Article  CAS  Google Scholar 

  17. de Graaf G, Engelen JJM, Gijsbers ACJ, Hochstenbach R, Hoffer MJV, Kooper AJA, et al. Estimates of live birth prevalence of children with Down syndrome in the period 1991–2015 in the Netherlands. J Intellect Disabil Res. 2017;61:461–70.

    Article  Google Scholar 

  18. Samura O, Sekizawa A, Suzumori N, Sasaki A, Wada S, Hamanoue H, et al. Current status of non-invasive prenatal testing in Japan. J Obstet Gynaecol Res. 2017;43:1245–55.

    Article  Google Scholar 

  19. Sasaki A, Sago H. Equipoise of recent estimated Down syndrome live births in Japan. Am J Med Genet A. 2019;179:1815–9.

    PubMed  Google Scholar 

  20. de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A. 2015;167A:756–67.

    Article  Google Scholar 

  21. Wu J, Morris JK. The population prevalence of Down’s syndrome in England and Wales in 2011. Eur J Hum Genet. 2013;21:1016–9.

    Article  Google Scholar 

  22. de Groot-van der Mooren M, de Graaf G, Weijerman ME, Hoffer MJV, Knijnenburg J, van der Kevie-Kersemaekers AMF, et al. Does non-invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population-based register study. Prenat Diagn. 2021

  23. Nishiyama M, Sekizawa A, Ogawa K, Sawai H, Nakamura H, Samura O, et al. Factors affecting parental decisions to terminate pregnancy in the presence of chromosome abnormalities: a Japanese multicenter study. Prenat Diagn. 2016;36:1121–6.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all the registered facilities for their cooperation in providing cycle-specific information to the ART registry. We thank Charles Allan, PhD, and Susan Furness, PhD, from Edanz (https://jp.edanz.com/ac) for editing drafts of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seung Chik Jwa.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the institutional review board at the Saitama Medical University (Approval number 875; February 2018) and the ethics committee of the JSOG (Approval number 78; September 2018).

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jwa, S.C., Namba, A., Tamaru, S. et al. Down syndrome live births following assisted reproductive technology in Japan: a nationwide survey between 2007 and 2016. J Assist Reprod Genet 39, 1625–1631 (2022). https://doi.org/10.1007/s10815-022-02501-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-022-02501-4

Keywords

Navigation